| Mr Gabriel Martinez-rodriguez, MD | |
|
San Cristobal Anexo Torre I, Ponce, PR 00780 | |
| (787) 848-2100 | |
| (787) 813-1836 |
| Full Name | Mr Gabriel Martinez-rodriguez |
|---|---|
| Gender | Male |
| Speciality | Infectious Disease |
| Experience | 34 Years |
| Location | San Cristobal Anexo Torre I, Ponce, Puerto Rico |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023063104 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 11939 (Puerto Rico) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| San Luke's Memorial Hospital Inc | Ponce, PR | Hospital |
| Entity Name | Med Centro Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295727147 PECOS PAC ID: 5890692131 Enrollment ID: O20031216000213 |
News Archive
By all accounts, Republicans have, so far, offered almost no specifics. They claim that they're willing to raise $800 billion in revenue by closing loopholes, but they refuse to specify which loopholes they would close; they are demanding large cuts in spending, but the specific cuts they have been willing to lay out wouldn't come close to delivering the savings they demand. It's a very peculiar situation.
"An antibiotic used to treat severe bacterial infections showed promise at treating a highly drug-resistant and deadly form of tuberculosis [TB]," according to a study conducted by U.S. government and South Korean researchers and published in the New England Journal of Medicine on Wednesday, Reuters reports (Steenhuysen, 10/17).
On January 26, 2010, the Food and Drug Administration (FDA) released a key draft guidance document, Guidance for Industry Assessment of Abuse Potential of Drugs. When finalized, this guidance will represent the FDA's current position on the abuse potential of drugs. Noteworthy within the document, Good Laboratory Practices (GLP) specified in the Guidance for Industry S7A Safety 471 Pharmacology Studies for Human Pharmaceuticals and in FDA regulations, 21 CFR 472 part 58, now also apply to abuse potential studies in animals.
Progress towards the elimination of trachoma as a public health problem has been substantial, but the COVID-19 pandemic has disrupted community-based control efforts.
WuXi AppTec, a leading open-access R&D capability and technology platform company serving the global pharmaceutical, biotechnology, and medical device industries, announced today that it has formed a strategic alliance with MedImmune, the global biologics research and development arm of AstraZeneca.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Gabriel Martinez-rodriguez, MD Po Box 34239, Ponce, PR 00734-0239 Ph: (787) 813-1836 | Mr Gabriel Martinez-rodriguez, MD San Cristobal Anexo Torre I, Ponce, PR 00780 Ph: (787) 848-2100 |
News Archive
By all accounts, Republicans have, so far, offered almost no specifics. They claim that they're willing to raise $800 billion in revenue by closing loopholes, but they refuse to specify which loopholes they would close; they are demanding large cuts in spending, but the specific cuts they have been willing to lay out wouldn't come close to delivering the savings they demand. It's a very peculiar situation.
"An antibiotic used to treat severe bacterial infections showed promise at treating a highly drug-resistant and deadly form of tuberculosis [TB]," according to a study conducted by U.S. government and South Korean researchers and published in the New England Journal of Medicine on Wednesday, Reuters reports (Steenhuysen, 10/17).
On January 26, 2010, the Food and Drug Administration (FDA) released a key draft guidance document, Guidance for Industry Assessment of Abuse Potential of Drugs. When finalized, this guidance will represent the FDA's current position on the abuse potential of drugs. Noteworthy within the document, Good Laboratory Practices (GLP) specified in the Guidance for Industry S7A Safety 471 Pharmacology Studies for Human Pharmaceuticals and in FDA regulations, 21 CFR 472 part 58, now also apply to abuse potential studies in animals.
Progress towards the elimination of trachoma as a public health problem has been substantial, but the COVID-19 pandemic has disrupted community-based control efforts.
WuXi AppTec, a leading open-access R&D capability and technology platform company serving the global pharmaceutical, biotechnology, and medical device industries, announced today that it has formed a strategic alliance with MedImmune, the global biologics research and development arm of AstraZeneca.
› Verified 5 days ago
Juan Pablo Torres, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 917 Ave Tito Castro, Ponce, PR 00716 Phone: 787-840-4545 | |
Dr. George Paul Fahed, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 917 Ave Tito Castro, Torre Medica San Lucas Suite 701, Ponce, PR 00716 Phone: 787-290-5577 Fax: 787-848-6644 | |
Dr. Carlos A Gaona Reyes, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1214 Ave Munoz Rivera, Recinto Universitario, Ponce, PR 00717 Phone: 787-284-0383 Fax: 787-987-9310 | |
Rafael Jose Rivera, Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 909 Ave Tito Castro, Torre Medica San Lucassuite 504, Ponce, PR 00716 Phone: 787-651-1432 | |
Aurelio Garcia Medina, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: Mansion Del Lago Calle 3 # 89, Ponce, PR 00732 Phone: 787-247-2427 | |
Marian Couto, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2225 Ponce By Pass, Edif Parra Ste 603, Ponce, PR 00717 Phone: 787-492-2000 Fax: 787-813-0517 |